CClinicalTrials.gg
CompletedNCT05399914SenSyNoPPUpdated Sep 23, 2024

Feasibility and Reliability of Synchronized Non-invasive Intermittent Positive Pressure Ventilation in Preterm Infants After Birth

An observational study in Preterm Infant, Delivery Room and Respiratory Support, sponsored by University Hospital Tuebingen. Completed at 1 site in Germany. Per ClinicalTrials.gov, last updated 2024-09-23.

Sponsored by University Hospital Tuebingen · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
10
Sex
All
01

Study summary

The aim of this prospective observational study (pilot study) is to test if synchronized noninvasive positive pressure ventilation (S-NIPPV) is feasible and works appropriately during transition from intrauterine to extrauterine life in very preterm infants in the delivery room.

Read the detailed description

The study period will be the first 10 minutes after birth.

All patients will be non-invasively ventilated using an EVE NEO ventilator (CE 0482, Fritz Stephan GmbH, Gackenbach, Germany). A facemask will be used throughout the study period. Synchronization will be achieved using graseby capsule (Stephan, Vio Healthcare), which will be secured at the abdominal wall on the midaxillary line below the ribs. For the detection of spontaneous breaths respiratory induction plethysmography (RIP) is used. For this purpose, an extra small plethysmography belt (Sleepsense, Elgin, USA) is placed around the abdomen. The data of the plethysmography belts are processed and stored with the NewLifebox-XL (Advanced Life Diagnostics UG, Weener, Germany) and merged with the data from the ventilator for later evaluation.

Infants according to the clinician's assessment only needing CPAP will receive S-NIPPV with very low PIP levels. This enables to have enough ventilator breaths applied for analysis to obtain sufficient data about the synchronization rate of S-NIPPV in the delivery room and meanwhile consider the infant's safety by not applying high pressures where it might not be needed. The ventilator support settings will be PIP 10, PEEP 6 in the noninvasive pressure controlled assist control ventilation (nPC-ACV+) mode. In this mode every spontaneous breath is supported by a ventilator breath (if the triggering level is exceeded). The triggering level will be set at 0,5 to avoid autotriggering and unsupported breaths. The inspiratory time will be set at max. 0,3 sec. The backup ventilation rate is set at 60 per minute.The EVE NEO ventilator has in the nPC-ACV+ mode an option where the ventilator breaths are interrupted/stopped as soon as the graseby capsule detects a start of spontaneous expiration.

If the infant according to the clinician's assessment needs S-NIPPV (e.g. the infant is apnoeic, and/or heart rate is below 100 bpm), the pressure of S-NIPPV will be augmented to target PIP 20, PEEP 6 (unless clinical concerns require an adjustment). The respiratory support can be deescalated to PIP 10 once the clinician deems the higher pressure no longer necessary.

The following demographical characteristics will be collected from the patient charts (pseudonymized): gender, gestational age, birth weight, antenatal steroids, mode of delivery, reason for prematurity (prolong premature rupture of membrane, infection, pathologic CTG, pathological doppler, gestosis), time of cord clamping, umbilical cord pH, FiO2 requirement, APGAR.

The following interventions within the first 10 minutes after birth including the time will be noted: tactile stimulation, placement of an intravenous line, non-invasive surfactant administration, intubation, chest compression, administration of volume, catecholamine, blood or other medication.

02

Conditions studied

  • Preterm Infant
  • Delivery Room
  • Respiratory Support
  • Synchronized Noninvasive Positive Pressure Ventilation (SNIPPV)

Browse trials for

03

In context

Premature Birth

2,554 studies on the registry are indexed under Premature Birth; 498 are open to participants now.

This study's enrollment of 10 is below the median of 112 across 777 observational studies indexed under Premature Birth.

Browse Premature Birth studies →

Lead sponsor

University Hospital Tuebingen is the lead sponsor of 476 studies on the registry; 104 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Preterm infants born at University Hospital in Tübingen.

Inclusion criteria

  • Preterm infants with a gestational age (GA) between 26 ≥ and \< 32 weeks

Exclusion criteria

Exclusion Criteria:

  • Major congenital malformations
  • Refused parental consent (prenatal parental consent is necessary)
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
10 participants (actual)
Patient registry
No

Groups and cohorts

  • Preterm infants with a gestational age (GA) between 26 ≥ and < 32 weeks

    Other: S-NIPPV

Interventions

  • OtherS-NIPPV

    Synchronized noninvasive positive pressure ventilation during the first 10 minutes after birth.

06

What researchers measure

Primary outcomes

  1. Synchronisation rate

    Synchronisation rate (sensitivity/true positive rate) of S-NIPPV in the delivery room meaning the proportion of graseby triggered synchronized ventilator breaths with corresponding RIP signal related to all spontaneous breaths detected by RIP.

    Time frame: First 10 minutes after birth

Secondary outcomes

  1. False negative rate

    Proportion of non-synchronized ventilator breaths with corresponding RIP signal. This will be related to all spontaneous breaths detected by RIP.

    Time frame: First 10 minutes after birth

  2. False positive rate

    Proportion of graseby triggered ventilator breaths without corresponding RIP signal. This will be related to all ventilator breaths without a corresponding RIP signal (i.e. movement artefacts).

    Time frame: First 10 minutes after birth

  3. Proportion of artifacts

    Proportion of graseby triggered ventilator breaths without corresponding RIP signal. This will be related to all ventilator breaths.

    Time frame: First 10 minutes after birth

  4. Specificity (true negative rate)

    Proportion of ventilator breaths without corresponding RIP signal and with no graseby signal (i.e. during an apnoea). This will be related to all ventilator breaths without a corresponding RIP signal.

    Time frame: First 10 minutes after birth

  5. Proportion of back up breaths

    Proportion of ventilator breaths without corresponding RIP signal and with no graseby signal. This will be related to all ventilator breaths.

    Time frame: First 10 minutes after birth

  6. Proportion of time of synchronised breaths, non-synchronized breaths, periods of apnoea and periods of movement artefacts occure within the first ten minutes of respiratory support.

    Time frame: First 10 minutes after birth

  7. Time until the graseby capsule is attached to the infant's abdomen and the proportion of infants in whom the graseby capsule is attached within the first two minutes after birth.

    Time frame: First 10 minutes after birth

  8. Proportion of time non invasive ventilator breaths will be applied.

    Time frame: First 10 minutes after birth

  9. Peak inspiratory pressure (PIP)

    Time frame: First 10 minutes after birth

  10. Positive end expiatory pressure (PEEP)

    Time frame: First 10 minutes after birth

  11. Mean airway pressure (MAP)

    Time frame: First 10 minutes after birth

  12. Td (time delay) graseby

    Time between the initial increase of the abdominal RIP curve and the initial increase of the graseby curve.

    Time frame: First 10 minutes after birth

  13. Td (time delay) ventilator

    Time between the initial increase of the graseby curve and the beginning of the pressure curve.

    Time frame: First 10 minutes after birth

  14. Ti ventilator

    Inspiratory time of a ventilator breath

    Time frame: First 10 minutes after birth

  15. Ti RIP

    Inspiratory time of a spontaneous breath

    Time frame: First 10 minutes after birth

  16. Ti excess

    Calculated: ((Ti ventilator - Ti RIP)/Ti RIP)) x 100

    Time frame: First 10 minutes after birth

  17. Swing RIP

    Amplitude of the RIP curve calculated by subtracting the baseline RIP from the peak RIP curve, which is a surrogate parameter for the patient's respiratory effort.

    Time frame: First 10 minutes after birth

  18. Number of tactile stimulations and other interventions on the patient

    Number of tactile stimulations and other interventions on the patient (e.g. placement of intravenous line, non-invasive administration of surfactant, intubation, chest compression) are documented by video analysis.

    Time frame: First 10 minutes after birth

  19. Heart rate

    Time frame: First 10 minutes after birth

  20. Oxygen saturation

    Time frame: First 10 minutes after birth

  21. Fraction of inspired oxygen

    Time frame: First 10 minutes after birth

07

Study locations

1 site
  • University Hospital Tuebingen
    Tuebingen, Baden-Wuerttemberg 72076, Germany
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 23, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05399914
Lead sponsor
University Hospital Tuebingen
Responsible party
Sponsor
First posted
Jun 1, 2022
Start date
Apr 22, 2022
Primary completion
Oct 11, 2023
Completion
Oct 11, 2023
Last update
Sep 23, 2024
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion